Medial amygdala ERα neurocircuits in the regulation of physical activity

内侧杏仁核 ERα 神经回路在身体活动调节中的作用

基本信息

  • 批准号:
    9889101
  • 负责人:
  • 金额:
    $ 24.63万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2018
  • 资助国家:
    美国
  • 起止时间:
    2018-03-15 至 2022-03-14
  • 项目状态:
    已结题

项目摘要

 DESCRIPTION (provided by applicant): The current application aims to map the medial amygdala (MeA) estrogen receptor alpha (ERα) neurocircuits that are essential for physical activity and body weight control. Our studies will not only advance our current understanding about the physical activity control and the development of obesity in general but also identify new feasible intervention targets for the development of novel therapeutic approaches to combat sedentary behaviors. Therefore, this proposed research is directly relevant to public health and the NIH's mission. I have four years of postdoctoral research experience when submitting this application (07/2011-07/2015). My long- term goal is to establish myself as an independent investigator in the area of central regulation of physical activity and metabolism. In order to develop an independent researcher in this field, I will use my K99-funded mentored period to (1) gain new training in exercise physiology to compare different aspects of treadmill exercise and voluntary wheel running behavior in mouse model; (2) implement the most advanced knowledge about physical activity/metabolism and cutting-edge techniques in the field of central regulation of metabolic behavior; (3) advance grantsmanship, project and laboratory management skills, mentoring, teaching skills, etc. I will start looking for university faculty positions towards the end of the first year of the K99 stage to ensure the smooth transition to the R00 phase. The ovary hormone, estrogen, plays an important role in maintaining normal energy homeostasis by regulating food intake and physical activity. While ERα expressed by pro-opiomelanocortin (POMC) in the hypothalamic arcuate nucleus (ARC) modulates food intake, estrogen- responsive neurons influencing locomotion remain undefined. Recently, we demonstrated that ERα expressed by the Single Minded 1 (SIM1) neurons in the MeA dedicated to promoting locomotion in both males and females. Additionally, acute activation of MeA SIM1 neurons led to short term increase of locomotion. These suggest that ERα expressed by MeA SIM1 neurons constitute part of a previously undefined locomotor circuit that is used in both males and females. Here, we plan to further define and understand how this MeA estrogen- responsive neural circuit promotes locomotion. In the aim 1 and 2 (K99 phase), we will (1) test if ERα in the MeA is required for the coordinated control of locomotor activity, body weight and exercise-induced metabolic benefits by using mouse/virus genetic loss-of-function and gain-of-function models to specifically delete or overexpress whole ERα population in the MeA; (2) further demonstrate if activation/inhibition of MeA ERα neurons increases/decreases locomotion by using a novel technology termed Designer Receptors Exclusively Activated by Designer Drugs (DREADD). With this information in hand, we will then start aim 3 (R00 phase) to map the downstream neural circuits of MeA ERα neurons and identify the critical MeA downstream neural circuits where estrogen acts to stimulate locomotion and prevent obesity. The proposed studies represent logical extensions to our previous work and offer an excellent opportunity to understand the neural basis of estrogenic regulation of locomotion, not only in females but also in males.
 描述(由申请人提供):本申请旨在绘制对身体活动和体重控制至关重要的内侧杏仁核(MeA)雌激素受体α(ERα)神经回路。我们的研究不仅将推进我们目前对身体活动控制和肥胖发展的理解,而且还将确定新的可行干预目标,以开发新的治疗方法来对抗久坐行为。因此,这项拟议中的研究与公共卫生和NIH的使命直接相关。我有四年的博士后研究经验时提交此申请(07/2011-07/2015)。我的长期目标是使自己成为身体活动和新陈代谢的中枢调节领域的独立研究者。为了在这一领域发展独立的研究人员,我将利用我的K99资助的指导期间(1)获得运动生理学的新培训,以比较小鼠模型中跑步机运动和自愿轮跑行为的不同方面;(2)实施关于身体活动/代谢的最先进知识和代谢行为中枢调节领域的尖端技术;(3)推进项目、实验室管理技能、指导、教学技能等,我将在K99阶段第一年年底开始寻找大学教师职位,以确保顺利过渡到R 00阶段。卵巢激素,雌激素,通过调节食物摄入和身体活动在维持正常能量平衡方面起着重要作用。虽然下丘脑弓状核(ARC)中阿黑皮素原(POMC)表达的ERα调节食物摄入,但影响运动的雌激素反应神经元仍不清楚。最近,我们证明ERα由MeA中的单一心智1(SIM 1)神经元表达,致力于促进男性和女性的运动。此外,MeA SIM 1神经元的急性激活导致运动的短期增加。这些表明,由MeA SIM 1神经元表达的ERα构成了先前未定义的运动回路的一部分,该运动回路在男性和女性中都使用。在这里,我们计划进一步定义和理解这种MeA雌激素反应神经回路如何促进运动。在目标1和2中(K99期),我们将(1)通过使用小鼠/病毒遗传功能丧失和功能获得模型特异性删除或过表达MeA中的整个ERα群体,测试MeA中的ERα是否是协调控制运动活性、体重和运动诱导的代谢益处所必需的;(2)通过一种新的被设计者药物独家激活的设计者受体(DREADD)技术进一步证明MeA ERα神经元的激活/抑制是否增加/减少运动。有了这些信息,我们将开始目标3(R 00阶段),绘制MeA ERα神经元的下游神经回路,并确定雌激素刺激运动和预防肥胖的关键MeA下游神经回路。拟议的研究代表了我们以前的工作的逻辑扩展,并提供了一个很好的机会来了解雌激素调节运动的神经基础,不仅在女性,而且在男性。

项目成果

期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
α-Ketoglutaric acid ameliorates hyperglycemia in diabetes by inhibiting hepatic gluconeogenesis via serpina1e signaling.
  • DOI:
    10.1126/sciadv.abn2879
  • 发表时间:
    2022-05-06
  • 期刊:
  • 影响因子:
    13.6
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Pingwen Xu其他文献

Pingwen Xu的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Pingwen Xu', 18)}}的其他基金

Testosterone and estrogen signaling pathways in the medial amygdala interact to control energy homeostasis
内侧杏仁核中的睾酮和雌激素信号通路相互作用以控制能量稳态
  • 批准号:
    10443875
  • 财政年份:
    2020
  • 资助金额:
    $ 24.63万
  • 项目类别:
Testosterone and estrogen signaling pathways in the medial amygdala interact to control energy homeostasis
内侧杏仁核中的睾酮和雌激素信号通路相互作用以控制能量稳态
  • 批准号:
    10262923
  • 财政年份:
    2020
  • 资助金额:
    $ 24.63万
  • 项目类别:
Testosterone and estrogen signaling pathways in the medial amygdala interact to control energy homeostasis
内侧杏仁核中的睾酮和雌激素信号通路相互作用以控制能量稳态
  • 批准号:
    10649532
  • 财政年份:
    2020
  • 资助金额:
    $ 24.63万
  • 项目类别:
Testosterone and estrogen signaling pathways in the medial amygdala interact to control energy homeostasis
内侧杏仁核中的睾酮和雌激素信号通路相互作用以控制能量稳态
  • 批准号:
    10632260
  • 财政年份:
    2020
  • 资助金额:
    $ 24.63万
  • 项目类别:
Testosterone and estrogen signaling pathways in the medial amygdala interact to control energy homeostasis
内侧杏仁核中的睾酮和雌激素信号通路相互作用以控制能量稳态
  • 批准号:
    10713363
  • 财政年份:
    2020
  • 资助金额:
    $ 24.63万
  • 项目类别:
Medial amygdala ERα neurocircuits in the regulation of physical activity
内侧杏仁核 ERα 神经回路在身体活动调节中的作用
  • 批准号:
    9109788
  • 财政年份:
    2016
  • 资助金额:
    $ 24.63万
  • 项目类别:
Medial amygdala ERα neurocircuits in the regulation of physical activity
内侧杏仁核 ERα 神经回路在身体活动调节中的作用
  • 批准号:
    9323423
  • 财政年份:
    2016
  • 资助金额:
    $ 24.63万
  • 项目类别:

相似国自然基金

Agonist-GPR119-Gs复合物的结构生物学研究
  • 批准号:
    32000851
  • 批准年份:
    2020
  • 资助金额:
    24.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

S1PR1 agonistによる脳血液関門制御を介した脳梗塞の新規治療法開発
S1PR1激动剂调节血脑屏障治疗脑梗塞新方法的开发
  • 批准号:
    24K12256
  • 财政年份:
    2024
  • 资助金额:
    $ 24.63万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
AHR agonistによるSLE皮疹の新たな治療薬の開発
使用 AHR 激动剂开发治疗 SLE 皮疹的新疗法
  • 批准号:
    24K19176
  • 财政年份:
    2024
  • 资助金额:
    $ 24.63万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
  • 批准号:
    10578068
  • 财政年份:
    2023
  • 资助金额:
    $ 24.63万
  • 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
  • 批准号:
    10933287
  • 财政年份:
    2023
  • 资助金额:
    $ 24.63万
  • 项目类别:
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor
用松弛素受体小分子激动剂靶向乳腺癌微环境
  • 批准号:
    10650593
  • 财政年份:
    2023
  • 资助金额:
    $ 24.63万
  • 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
  • 批准号:
    10649275
  • 财政年份:
    2023
  • 资助金额:
    $ 24.63万
  • 项目类别:
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
在男性和女性健康志愿者中进行的一项随机双盲安慰剂对照 1 期 SAD 研究,旨在评估 ABCA1 激动剂 CS6253 的安全性、药代动力学和短暂生物标志物变化
  • 批准号:
    10734158
  • 财政年份:
    2023
  • 资助金额:
    $ 24.63万
  • 项目类别:
Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation
研究阿片类激动剂治疗 OUD 患者结果的机制:解开睡眠和昼夜节律对渴望和情绪调节的影响
  • 批准号:
    10784209
  • 财政年份:
    2023
  • 资助金额:
    $ 24.63万
  • 项目类别:
A novel nanobody-based agonist-redirected checkpoint (ARC) molecule, aPD1-Fc-OX40L, for cancer immunotherapy
一种基于纳米抗体的新型激动剂重定向检查点 (ARC) 分子 aPD1-Fc-OX40L,用于癌症免疫治疗
  • 批准号:
    10580259
  • 财政年份:
    2023
  • 资助金额:
    $ 24.63万
  • 项目类别:
Identification and characterization of a plant growth promoter from wild plants: is this a novel plant hormone agonist?
野生植物中植物生长促进剂的鉴定和表征:这是一种新型植物激素激动剂吗?
  • 批准号:
    23K05057
  • 财政年份:
    2023
  • 资助金额:
    $ 24.63万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了